Key result
Pediatric CKD is linked to elevated plasma BNP that fails to decrease after hemodialysis.
Why the study?
Pediatric CKD patients and kidney transplant recipients face increased cardiovascular disease risk, and BNP measurement has been recommended as a cardiovascular risk biomarker in this high-risk population.
Are plasma BNP levels elevated in pediatric patients with chronic kidney disease and renal transplant recipients compared to healthy controls?
Cross-Sectional (n=132)
No
Are plasma BNP levels elevated in pediatric patients with chronic kidney disease and renal transplant recipients compared to healthy controls?
Pediatric CKD patients, especially those on hemodialysis, exhibit elevated plasma BNP levels that do not decrease post-dialysis, indicating a potentially higher risk for future cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Elevated BNP in pediatric CKD may signal higher CV risk; leaves open whether BNP monitoring aids risk stratification or management in children.
Pediatric chronic kidney disease (CKD) patients, as well as kidney transplant patients, are at an increased risk of developing cardiovascular disease. BNP measurement, as a biomarker of cardiovascular risk, has been recommended to this high-risk population. Plasma BNP levels were measured in 56 CKD children in either pre-dialysis stage, hemodialysis (HD) or renal transplant recipients (RTRs) and in 76 sex- and age-matched healthy controls. BNP levels were investigated in HD children, before and after the completion of their HD session. BNP levels in total CKD population, in pre-dialysis stage patients and on HD were significantly higher, compared to the respective controls. HD children had higher BNP levels compared to CKD patients in the pre-dialysis stage. Moreover, post-HD BNP concentration was slightly higher than pre-HD, with the difference being marginally statistically significant. BNP was positively correlated with eGFR, creatinine, cystatin-C and parathormone and negatively with albumin and 25-hydroxyvitamin D. A positive correlation between BNP concentration and the ratio of E/A in pulse-wave Doppler echocardiography was also observed. In conclusion, CKD pediatric patients, mainly those undergoing HD, have high plasma BNP levels which do not decrease after the HD session. This is indicative of a greater risk for future cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Garoufi et al. (2022) conducted a cross-sectional in Pediatric chronic kidney disease and renal transplant recipients (n=132). Plasma BNP measurement vs. Healthy controls was evaluated on Plasma BNP levels. Plasma BNP levels were significantly higher in pediatric CKD patients, particularly those on hemodialysis, compared to healthy controls, and did not decrease after hemodialysis sessions.
Synapse has enriched 10 related papers. Consider them for comparative context: